Adjuvant therapy for colon cancer: A review of current approaches and future directions

S. R. Alberts, C. Erlichman

Research output: Contribution to journalReview articlepeer-review

Abstract

Adjuvant therapy for colon cancer has had a significant impact on the survival of patients following curative resection. Patients most likely to benefit are those with Dukes' C colon cancer. Currently, the combination of 5-fluorouracil and levamisole is standard adjuvant therapy for this group of patients. This article reviews the development of adjuvant therapy for colon cancer, the current approaches to treatment, and describes adjuvant chemotherapy studies that are currently underway.

Original languageEnglish (US)
Pages (from-to)40-46
Number of pages7
JournalSeminars in Colon and Rectal Surgery
Volume7
Issue number1
StatePublished - Apr 17 1996

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Fingerprint Dive into the research topics of 'Adjuvant therapy for colon cancer: A review of current approaches and future directions'. Together they form a unique fingerprint.

Cite this